Werfen

Werfen is a global specialized diagnostics company focused on in vitro diagnostics (IVD), hemostasis, acute care diagnostics, autoimmunity, transfusion medicine, and advanced laboratory testing solutions. Founded in 1966 and headquartered in Barcelona, Spain, the company develops and manufactures diagnostic systems used by hospitals, clinical laboratories, blood banks, and healthcare institutions in more than 100 countries.

Werfen’s portfolio includes coagulation analyzers, blood gas analyzers, critical care diagnostics, autoimmune disease testing, transfusion medicine technologies, and laboratory automation systems. Through its globally recognized brands—including Instrumentation Laboratory (IL), Inova Diagnostics, and Biokit—the company provides highly accurate diagnostic solutions that support emergency medicine, critical care, hematology, immunology, and transfusion services.

The company invests extensively in research and development, automation, digital laboratory technologies, and precision diagnostics to improve clinical decision-making and laboratory efficiency. Its global manufacturing facilities operate under strict international quality standards and comply with regulatory requirements established by the US FDA, European IVDR, ISO 13485, and other major healthcare authorities.

With nearly six decades of scientific expertise and innovation, Werfen has become one of the world’s leading providers of specialty diagnostic solutions, supporting healthcare professionals in delivering faster, more reliable, and clinically meaningful diagnostic results.